CYCC - Cyclacel Pharmaceuticals EPS misses by $1.66 August, 12 2020 04:19 PM Cyclacel Pharmaceuticals Inc. Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q2 GAAP EPS of -$2.13 misses by $1.66.Shares -6.8%.Press ReleaseMore news on: Cyclacel Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,